View all Medical Crossfire CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from AstraZeneca.


Medical Crossfire®: Leveraging Liquid Biopsies in Tumor Characterization for NSCLC Therapy

Release Date: January 31, 2017
Expiration Date: January 31, 2018
Media: Internet - based

 

Activity Overview

Medical Crossfire®: Leveraging Liquid Biopsies in Tumor Characterization for NSCLC Therapy is a dynamic expert panel discussion designed to update oncology healthcare professionals on current applications for liquid biopsies in personalizing care for patients with lung cancer. This activity consists of 4 video modules that will present multiple expert points of view on this rapidly developing area of molecular testing:

CME Activity Table of Contents

  • Module 1 will present an overview of the role of tumor genomic analysis in selecting therapy, as well as the limits of conventional biopsy methods.
  • Module 2 will provide the scientific basis for liquid-based biopsies in mutational testing.
  • Module 3 will incorporate case-based discussions on the application of liquid biopsies, including considerations of when a tissue- or liquid-based approach should be considered.
  • Module 4 will address ongoing areas of investigation and potential future applications for liquid-based biopsies.

  

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review video files/content until you finish the presentation.
  • At the end of the activity, "educational content/video files" will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience

This educational activity is directed toward medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved in the treatment of patients with lung cancer.

Learning Objectives

Upon completion of this activity, participants will be better prepared to:

  • Discuss the benefits and limitations of liquid biopsies, particularly as they compare with conventional biopsies
  • Explain the fundamental basic science that underpins liquid biopsies
  • Differentiate between available and emerging testing technologies
  • Apply and evaluate key evidence and patient characteristics that support the clinical utility of specific testing modalities


Faculty, Staff, and Planners' Disclosures

Chair

Benjamin P. Levy, MD
Medical Oncologist
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program
Mount Sinai Health System
Associate Director, Cancer Clinical Trials Office
Mount Sinai Hospital
New York, NY

Disclosure: Consultant: Genentech, Eli Lilly, AstraZeneca, Celgene, Biodesix, Pfizer.

Faculty

Philip C. Mack, PhD
Adjunct Professor
UC Davis Comprehensive Cancer Center
Sacramento, CA
Professor and Vice President
California Northstate University
Elk Grove, CA

Disclosure: Grant/Research Support: Boehringer Ingelheim; Consultant: AstraZeneca, Novartis, MolecularMD, Apton Biosystems, Guardant Health

Sarah B. Goldberg, MD, MPH
Assistant Professor of Internal Medicine
Medical Oncology
Yale Cancer Center
New Haven, CT

Disclosure: Grant/Research Support: AstraZeneca.

Geoffrey R. Oxnard, MD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA

Disclosure: Consultant: Ariad, AstraZeneca, Boehringer Ingelheim, Genentech, Inivata.

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive, Suite 110
Cranbury, NJ 08512
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705
info@gotoper.com

 

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

PER® Practice Pulse
Practice Pattern Questions
How often do you attend society oncology/hematology meetings? (ASCO, ASH, SABCS)
Practice Pattern Questions
What is the most significant barrier to implementing new information in your clinical practice?



Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728
Filter By